scorecardresearch
Add as a preferred source on Google
Wednesday, August 12, 2026
TopicRemdesivir

Topic: Remdesivir

WHO adds Pfizer’s 2-drug antiviral Paxlovid to Covid recommendations for high-risk patients

WHO Guideline Development Group recommends oral drug Paxlovid for patients with non-severe Covid-19 who are at high risk of hospitalisation.

Once a Covid ‘wonder drug’, Remdesivir’s sales hit low in Nov, didn’t soar again with 3rd wave

Rs 6.4 cr worth of Remdesivir was sold in November, and Rs 12 cr in December, compared to Rs 287 cr in April 2021. Doctors say milder cases and better understanding is reason why.

Need legal advice on dealing with Covid fraud? These lawyer groups promise to help for free

Lawyers against Covifraud and India pro bono lawyers are among the groups that have organised through social media to offer advice and aid to victims of pandemic-related frauds.

Growing plasma, remdesivir use will help Covid virus mutate, become stronger: Ex-ICMR scientist

Dr Raman Gangakhedkar, face of ICMR during Covid briefings last year, said India could become breeding ground for several mutants if it does not adhere to evidence-based treatment. 

Dexamethasone, remdesivir, plasma, doxycycline: Which works for Covid and which doesn’t

Most drugs patients are being prescribed have not proven to help with treatment of Covid-19. Here is a list of all such drugs and therapies their scientific merit.

Delhi Police busts 4 for remdesivir ‘black marketing’, says inter-state gangs involved

Delhi Police has so far recovered 81 remdevisir injections and has also tracked down WhatsApp groups of inter-state gangs allegedly running the black marketing racket.

What’s on our minds in peak pandemic? ‘Oxygen’, ‘plasma’ and ‘remdesivir’, says Google

Indian social media has been inundated with posts about Covid — from availability or lack of oxygen and hospital beds to treatment options. What an analysis of Google Trends found.

BJP again caught in a remdesivir row in Maharashtra, this time for distributing drug

BJP’s Shirish Chaudhari, who belongs to Amalner in Jalgaon, sold large stocks of Cadila Healthcare’s Remdac & Bruck Pharma’s Corovir in Nandurbar & Jalgaon districts. 

How BJP tried to buy remdesivir directly from firm & gaps in Thackeray govt fanned controversy

Mumbai Police questioned a Bruck Pharma pharma executive after stock of remdesivir, a Covid drug in shortage, was found. But MVA minister already knew BJP was procuring it from the firm.

India has a remdesivir problem — doesn’t know where to get it, unsure if it treats Covid

As India’s vaccine trouble intensifies, doctors and patients’ kin alike have come to depend on a drug whose effectiveness remains unproven — the anti-viral injection remdesivir.

On Camera

Free UPI was a policy success and an economic distortion

Six years of zero MDR delivered unprecedented digital payments at the price of underinvestment, rising fraud risk, and market concentration.

Birlas to Tatas, all await West Bengal’s new industrial policy, says state BJP chief Samik Bhattacharya

In interview with ThePrint, RS MP says new policy will incentivise industry. Bengal’s industrialisation hit pause after 2008 Singur land agitation drove away Tata Nano project.

As India-China face-off in Arunachal Pradesh, MEA says state of border will reflect state of ties

Face-off happened late July when patrol parties of 2 countries came face to face in remote Taksing village. The Chinese are said to have returned in early August.

Guru RSS is cautioning shishya Modi govt. Bhagwat’s endorsement of Gen Z has an Indira lesson

It’s evident Bhagwat was watching from a distance and was worried about youth’s anger towards Modi govt. The first thing he did was to demolish any criticism of Gen Z protesters as anti-national.